CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

New manager at JULABO UK

Since April 2015, Gary Etherington has assumed the management of the JULABO subsidiary in the UK.
Gary Etherington has significant experience within the laboratory market in the UK, Ireland and the USA. He started his career as application support specialist. In the course of his career he successfully proved himself in both product management and sales. He has previously been part of the JULABO team before as Sales & Marketing Manager at JULABO USA. Further missions were calorimetry specialist companies. Lately he was responsible for the worldwide sales of laboratory products. With immediate effect he actively contributes his extensive contacts in the industry established over many years as well as his comprehensive experience of the laboratory markets and sales to JULABO for the markets in the UK and Ireland.
JULABO UK provides its customers and partners with the complete product and service portfolio of JULABO. With a dedicated team, comprehensive knowledge and long-time experience the subsidiary covers all areas of sales, service and support.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026